Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adenine/administration & dosage 1
- Adenine/adverse effects 1
- Adenine/analogs & derivatives 1
- Adenine/contraindications 1
- Administration, Oral 1
- Adolescent 4
- Adult 6
- AIDS Serodiagnosis 1
- AIDS Serodiagnosis / standards 1
- Anti-HIV Agents 2
- Anti-Retroviral Agents 1
- Anti-Retroviral Agents/administration & dosage 1
- Anti-Retroviral Agents/adverse effects 1
- Anti-Retroviral Agents/contraindications 1
- Antibiotic Prophylaxis 1
- Blotting, Western 1
- Brief Report 1
- Centers for Disease Control and Prevention, U.S. 1
- Child 3
- Child, Preschool 1
- Delivery, Obstetric 1
- Deoxycytidine/administration & dosage 1
- Deoxycytidine/adverse effects 1
- Deoxycytidine/analogs & derivatives 1
- Deoxycytidine/contraindications 1
- diagnosis 1
- Diagnostic Tests, Routine 1
- Diagnostic Tests, Routine/Standards 1
- diagnostic use 1
- Disease Outbreaks/Prevention & Control 1
- Drug Labeling 1
- Emigrants and Immigrants 1
- Epidemiological Monitoring 1
- Ethiopia 1
- False Positive Reactions 1
- Female 8
- Haiti 1
- Health Facilities 1
- Health Personnel* 1
- Health Policy 1
- Heterosexuality 1
- HIV 2
- HIV-1 1
- HIV Antibodies 1
- HIV Infections 9
- HIV Infections / prevention & control 1
- HIV Infections/prevention & control 1
- HIV Infections/transmission 1
- HIV Seropositivity 1
- Homosexuality 1
- Humans 9
- Immunoenzyme Techniques 1
- Incidence 2
- Infant 4
- Infant, Newborn 3
- Infectious Disease Transmission, Vertical 5
- Labor, Obstetric 1
- Lactation 1
- Male 1
- Mass Screening 1
- Maternal Welfare 1
- Organophosphonates/administration & dosage 1
- Organophosphonates/adverse effects 1
- Organophosphonates/contraindications 1
- Perinatal 1
- Pharmaceutical Preparations 1
- Population Surveillance 1
- Preconception Care 1
- Preconception care 1
- Pregnancy 10
- Pregnancy Complications 1
- Pregnancy Complications, Infectious 6
- Pregnancy Complications, Infectious/Prevention & Control 1
- Pregnancy Complications, Infectious/prevention & control 1
- Prenatal Care 1
- Prenatal Diagnosis 1
- Prevalence 1
- Prospective Studies 1
- Quality of Life 1
- Randomized Controlled Trials as Topic 1
- Reproductive Health 1
- Residence Characteristics/statistics & numerical data 1
- Retrospective Studies 2
- Risk 1
- Russia 1
- Sexual Behavior 2
- Sexual Health 1
- Sexually Transmitted Diseases 1
- Time Factors 1
- Travel/statistics & numerical data 1
- Uganda 1
- Ukraine 1
- United States 3
- Young Adult 3
- Zidovudine 2
- Zika Virus Infection/Prevention & Control 1
- Zika Virus Infection/Transmission 1
Personal Author
Corporate Author
Place as Subject
Resource Type General
Resource Type Specific
Keywords
- Anti-Retroviral Agents 1
- antiretroviral 2
- Antiretroviral 1
- ARV 1
- breastfeeding 1
- cancer 1
- Chemoprevention 1
- Child 1
- Child, Preschool 1
- children 2
- Chlorination 1
- country of birth 1
- exposed 1
- Female 2
- HIV 5
- HIV Infections 2
- Household water treatment 1
- Humans 2
- Incidence 2
- incidence 1
- Infant 1
- Infant, Newborn 2
- infant feeding 1
- infants 1
- Infectious Disease Transmission, Vertical 1
- Male 1
- natality 1
- Neoplasms 1
- New Jersey 1
- perinatal 2
- Population Surveillance 1
- Pregnancy 1
- pregnancy 1
- Pregnancy Complications, Infectious 1
- prevention of mother-to-child transmission 1
- reproductive age 1
- Safe water storage 1
- United States 3
- women 1
Select all docs (Max 200)
1 -
14 of 14 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adenine/administration & dosage (1)
- Adenine/adverse effects (1)
- Adenine/analogs & derivatives (1)
- Adenine/contraindications (1)
- Administration, Oral (1)
- Adolescent (4)
- Adult (6)
- AIDS Serodiagnosis (1)
- AIDS Serodiagnosis / standards (1)
- Anti-HIV Agents (2)
- Anti-Retroviral Agents (1)
- Anti-Retroviral Agents/administration & dosage (1)
- Anti-Retroviral Agents/adverse effects (1)
- Anti-Retroviral Agents/contraindications (1)
- Antibiotic Prophylaxis (1)
- Blotting, Western (1)
- Brief Report (1)
- Centers for Disease Control and Prevention, U.S. (1)
- Child (3)
- Child, Preschool (1)
- Delivery, Obstetric (1)
- Deoxycytidine/administration & dosage (1)
- Deoxycytidine/adverse effects (1)
- Deoxycytidine/analogs & derivatives (1)
- Deoxycytidine/contraindications (1)
- diagnosis (1)
- Diagnostic Tests, Routine (1)
- Diagnostic Tests, Routine/Standards (1)
- diagnostic use (1)
- Disease Outbreaks/Prevention & Control (1)
- Drug Labeling (1)
- Emigrants and Immigrants (1)
- Epidemiological Monitoring (1)
- Ethiopia (1)
- False Positive Reactions (1)
- Female (8)
- Haiti (1)
- Health Facilities (1)
- Health Personnel* (1)
- Health Policy (1)
- Heterosexuality (1)
- HIV (2)
- HIV-1 (1)
- HIV Antibodies (1)
- HIV Infections (9)
- HIV Infections / prevention & control (1)
- HIV Infections/prevention & control (1)
- HIV Infections/transmission (1)
- HIV Seropositivity (1)
- Homosexuality (1)
- Humans (9)
- Immunoenzyme Techniques (1)
- Incidence (2)
- Infant (4)
- Infant, Newborn (3)
- Infectious Disease Transmission, Vertical (5)
- Labor, Obstetric (1)
- Lactation (1)
- Male (1)
- Mass Screening (1)
- Maternal Welfare (1)
- Organophosphonates/administration & dosage (1)
- Organophosphonates/adverse effects (1)
- Organophosphonates/contraindications (1)
- Perinatal (1)
- Pharmaceutical Preparations (1)
- Population Surveillance (1)
- Preconception Care (1)
- Preconception care (1)
- Pregnancy (10)
- Pregnancy Complications (1)
- Pregnancy Complications, Infectious (6)
- Pregnancy Complications, Infectious/Prevention & Control (1)
- Pregnancy Complications, Infectious/prevention & control (1)
- Prenatal Care (1)
- Prenatal Diagnosis (1)
- Prevalence (1)
- Prospective Studies (1)
- Quality of Life (1)
- Randomized Controlled Trials as Topic (1)
- Reproductive Health (1)
- Residence Characteristics/statistics & numerical data (1)
- Retrospective Studies (2)
- Risk (1)
- Russia (1)
- Sexual Behavior (2)
- Sexual Health (1)
- Sexually Transmitted Diseases (1)
- Time Factors (1)
- Travel/statistics & numerical data (1)
- Uganda (1)
- Ukraine (1)
- United States (3)
- Young Adult (3)
- Zidovudine (2)
- Zika Virus Infection/Prevention & Control (1)
- Zika Virus Infection/Transmission (1)
- Anti-Retroviral Agents (1)
- antiretroviral (2)
- Antiretroviral (1)
- ARV (1)
- breastfeeding (1)
- cancer (1)
- Chemoprevention (1)
- Child (1)
- Child, Preschool (1)
- children (2)
- Chlorination (1)
- country of birth (1)
- exposed (1)
- Female (2)
- HIV (5)
- HIV Infections (2)
- Household water treatment (1)
- Humans (2)
- Incidence (2)
- incidence (1)
- Infant (1)
- Infant, Newborn (2)
- infant feeding (1)
- infants (1)
- Infectious Disease Transmission, Vertical (1)
- Male (1)
- natality (1)
- Neoplasms (1)
- New Jersey (1)
- perinatal (2)
- Population Surveillance (1)
- Pregnancy (1)
- pregnancy (1)
- Pregnancy Complications, Infectious (1)
- prevention of mother-to-child transmission (1)
- reproductive age (1)
- Safe water storage (1)
- United States (3)
- women (1)
- :Branson, Bernard M. ;Fowler, Mary GlennJanuary 30, 2004
- :Lampe, Margaret A.Jul 11 2006 | Matern Child Health J. 10(Suppl 1):195-197.
- :Ivy, Wade ;Nesheim, Steve R.9 1 2015 | J Acquir Immune Defic Syndr. 70(1):62-66:BackgroundConcerns remain regarding the cancer risk associated with perinatal antiretroviral (ARV) exposure among infants. No excessive cancer risk ha...
- :Nesheim, Steven R. ;Wiener, Jeffrey12 15 2017 | J Acquir Immune Defic Syndr. 76(5):461-464:Background:An incidence of perinatally acquired HIV infection less than 1:100,000 live births is one of the Centers for Disease Control and Prevention...
- :Taylor, Allan W. ;Nesheim, Steven R.5 2017 | JAMA Pediatr. 171(5):435-442:IMPORTANCEPerinatal transmission of human immunodeficiency virus (HIV) can be reduced through services including antiretroviral treatment and prophyla...
- :Wesolowski, Laura G. ;Delaney, Kevin P.Jan 27 2011 | PLoS One. 6(1).:ObjectiveExamine whether false-positive HIV enzyme immunoassay (EIA) test results occur more frequently among pregnant women than among women who are ...
- :Henderson, Alexis C. ;Cholli, Preetam4 2024 | Expert Rev Anti Infect Ther. 22(4):153-167:Introduction:The HIV/AIDS epidemic has been one of the greatest challenges in global health, significantly affecting women of reproductive potential. ...
- :Little, Kristen M. ;Taylor, Allan W.1 2017 | Pediatr Infect Dis J. 36(1):66-71:ObjectivesUsing published, nationally-representative estimates, we calculated the total number of perinatally HIV-exposed and HIV-infected infants bor...
- :Lampe, Margaret A. ;Nesheim, Steven R.5 01 2023 | Pediatrics. 151(5):In 2012, the Centers for Disease Control and Prevention published a Framework for Elimination of Perinatal Transmission of HIV in the United States in...
- :Nesheim, Steven R. ;Linley, Laurie1 01 2018 | J Acquir Immune Defic Syndr. 77(1):23-30:Background.Diagnoses of HIV infection among children in the United States (US) have been declining; however, a notable percentage of diagnoses are amo...
- :Dasgupta, Sharoda ;Crim, Stacy M.7 2024 | Am J Prev Med. 67(1):32-45:Introduction:The sexual and reproductive health of cisgender women with HIV is essential for overall health and well-being. Nationally representative ...
- :Oduyebo, Titilope ;Igbinosa, IrogueJuly 29, 2016 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):On July 25, 2016, this report was posted online as an MMWR Early Release.CDC has updated its interim guidance for U.S. health care providers caring fo...
- :Smith, Dawn K. ;Thigpen, Michael C.Aug 10 2012 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Morbidity and mortality weekly report. 2012 Aug 10;61(31):586-9.In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infec...
- :Branson, Bernard M. ;Handsfield, H. HunterSeptember 22, 2006 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):"These recommendations for human immunodeficiency virus (HIV) testing are intended for all health-care providers in the public and private sectors, in...:current
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.